CD8+ T cells are capable of rejecting pancreatic islet xenografts

Transplantation

Volumn 70, Issue 6, 2000, Pages 896-906

  Yi, Shounan ^a   Feng, Ximin ^a   Hawthorne, Wayne ^a   Patel, Anita ^a   Walters, Stacey ^a   O'Connell, Philip J ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; FAS ANTIGEN; FAS LIGAND; GRANZYME B; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD8; PERFORIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; XENOGRAFT;

EID: 0034721481     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200009270-00007     Document Type: Article

References (32)

1. Delayed xenograft rejection
2. Cellular rejection in discordant xenografts when hyperacute rejection is prevented: Analysis using adoptive and passive transfer
3. T cell independence of macrophages and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection
4. Immunology of xenograft rejection
5. Xenogeneic skin graft rejection is especially dependent on CD4+ cells
6. Intragraft expression of cytokine transcripts during pig proislet xenograft rejection and tolerance in mice
7. CD4+ T-cell mediated destruction of xenografts within cell-impermeable membranes in the absence of CD8+ T cells and B cells
8. Fetal pig islet xenografts in NOD-Lt mice: The effect of peritransplant anti-CD4 monoclonal antibody and graft immunomodification on graft survival, and lack of expression of Gal (α1-3) Gal on endocrine cells
9. Effect of GK1.5 monoclonal antibody dosage on survival of pig proislet xenografts in CD4+ T cell-depleted mice
10. CD4+ T cells, without CD8+ or B lymphocytes, can reject xenogeneic skin grafts
11. Xenogeneic Transplantation
12. CD4+ T cells play a major role in xenogeneic human anti-pig cytotoxicity via the Fas/Fas ligand lytic pathway
13. Rejection of pancreatic islet xenografts does not require CD8+ T-lymphocytes
14. Pancreatic islet allograft and xenograft survival in CD8+ T-lymphocyte-deficient recipients
15. Donor antigen-presenting cell-independent rejection of islet xenografts
16. Islet allograft, islet xenograft, and skin allograft survival in CD8+ T lymphocyte-deficient mice
17. Targeted disruption of the MHC class II Aa gene in C57BL/6 mice
18. Characterization of the murine T cell surface molecule designated L3T4 identified by monoclonal antibody GK1.5: Similarity of L3T4 to the human Leu-3/T4 molecule
19. Xenogeneic monoclonal antibodies to lymphoid differentiation antigens
20. Mac-1: A macrophage differentiation antigen identified by monoclonal antibody
21. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment
22. The effect of a depleting anti-CD4 monoclonal antibody on T cells and fetal pig islet xenograft survival in various strains of mice
23. The cytokine and histological response in islet xenograft rejection is dependent upon species combination
24. Apoptosis detection by annexin V binding: A novel method for the quantitation of cell-mediated cytotoxicity
25. Evidence that multiple defects in cell-surface molecule interactions across species differences are responsible for diminished xenogeneic T cell responses
26. Species-restricted interactions between CD8 and the α3 domain of class I influence the magnitude of the xenogeneic response
27. Recognition of porcine major histocompatibility complex class I antigens by human CD8+ cytolytic T cell clones
28. Antigen presentation to cytotoxic T lymphocytes in vivo
29. MHC class I-restricted CTL responses to exogenous antigens
30. The strength of cell-mediated xenograft rejection in the mouse is due to the CD4+ indirect response
31. Rejection of cardiac xenografts by CD4+ or CD8+ T cells
32. Mechanism and biological significance of CD4-mediated cytotoxicity